AIM: To characterize the phenotype of Akt2/low-density-lipoprotein receptor double knockout (dKO) (Akt2/LDLr dKO) mice with respect to insulin resistance and features of atherosclerotic plaque progression. METHODS AND RESULTS: Metabolic profile and atherosclerotic plaque progression were compared between LDLr KO mice and Akt2/LDLr dKO mice. Total cholesterol, glucose, and insulin levels were significantly higher and oral glucose tolerance test (GTT) was more impaired in Akt2/LDLr dKO mice than in LDLr KO mice. Although atherosclerotic plaques at both the carotid artery and the aortic root of Akt2/LDLr dKO mice were significantly smaller (P < 0.05) compared with LDLr KO controls, plaque composition in these mice was more complex, showing 34-50% reduced collagen content (P < 0.01), 1.4-fold larger necrotic cores (P < 0.05) and six-fold more TUNEL-positive cells (P < 0.01). In situ zymography revealed a more than two-fold higher gelatinolytic activity in Akt2/LDLr dKO mice (P < 0.05). In vitro analyses showed that deletion of Akt2 caused decreased migration, proliferation, and collagen content of vascular smooth muscle cells (VSMCs) and disturbed the balance of metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) mRNA expression in macrophages and VSMCs. CONCLUSION: Akt2/LDLr dKO mice develop insulin resistance and complex atherosclerotic lesions. These phenotypic characteristics make Akt2/LDLr dKO mice an interesting mouse model to study the effects of insulin resistance on the development and progression of atherosclerosis.
AIM: To characterize the phenotype of Akt2/low-density-lipoprotein receptor double knockout (dKO) (Akt2/LDLr dKO) mice with respect to insulin resistance and features of atherosclerotic plaque progression. METHODS AND RESULTS: Metabolic profile and atherosclerotic plaque progression were compared between LDLr KO mice and Akt2/LDLr dKO mice. Total cholesterol, glucose, and insulin levels were significantly higher and oral glucose tolerance test (GTT) was more impaired in Akt2/LDLr dKO mice than in LDLr KO mice. Although atherosclerotic plaques at both the carotid artery and the aortic root of Akt2/LDLr dKO mice were significantly smaller (P < 0.05) compared with LDLr KO controls, plaque composition in these mice was more complex, showing 34-50% reduced collagen content (P < 0.01), 1.4-fold larger necrotic cores (P < 0.05) and six-fold more TUNEL-positive cells (P < 0.01). In situ zymography revealed a more than two-fold higher gelatinolytic activity in Akt2/LDLr dKO mice (P < 0.05). In vitro analyses showed that deletion of Akt2 caused decreased migration, proliferation, and collagen content of vascular smooth muscle cells (VSMCs) and disturbed the balance of metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) mRNA expression in macrophages and VSMCs. CONCLUSION:Akt2/LDLr dKO mice develop insulin resistance and complex atherosclerotic lesions. These phenotypic characteristics make Akt2/LDLr dKO mice an interesting mouse model to study the effects of insulin resistance on the development and progression of atherosclerosis.
Entities:
Keywords:
Akt2/LDLr dKO; Atherosclerosis; Diabetes; Mouse model
Authors: Noemi Rotllan; Aránzazu Chamorro-Jorganes; Elisa Araldi; Amarylis C Wanschel; Binod Aryal; Juan F Aranda; Leigh Goedeke; Alessandro G Salerno; Cristina M Ramírez; William C Sessa; Yajaira Suárez; Carlos Fernández-Hernando Journal: FASEB J Date: 2014-11-12 Impact factor: 5.191
Authors: Vladimir R Babaev; Lei Ding; Youmin Zhang; James M May; Stephen A Ramsey; Kasey C Vickers; MacRae F Linton Journal: Arterioscler Thromb Vasc Biol Date: 2019-02 Impact factor: 8.311
Authors: Amanda K Segedy; Amy L Pyle; Bin Li; Youmin Zhang; Vladimir R Babaev; Parmjit Jat; Sergio Fazio; James B Atkinson; MacRae F Linton; Pampee P Young Journal: Arterioscler Thromb Vasc Biol Date: 2014-10-02 Impact factor: 8.311
Authors: Noemi Rotllan; Amarylis C Wanschel; Ana Fernández-Hernando; Alessandro G Salerno; Stefan Offermanns; William C Sessa; Carlos Fernández-Hernando Journal: Circ Res Date: 2015-04-13 Impact factor: 17.367
Authors: MacRae F Linton; Vladimir R Babaev; Jiansheng Huang; Edward F Linton; Huan Tao; Patricia G Yancey Journal: Circ J Date: 2016-10-08 Impact factor: 2.993
Authors: Yu Jin; Yi Xie; Allison C Ostriker; Xinbo Zhang; Renjing Liu; Monica Y Lee; Kristen L Leslie; Waiho Tang; Jing Du; Seung Hee Lee; Yingdi Wang; William C Sessa; John Hwa; Jun Yu; Kathleen A Martin Journal: Arterioscler Thromb Vasc Biol Date: 2017-10-12 Impact factor: 8.311
Authors: Vladimir R Babaev; Katie E Hebron; Carrie B Wiese; Cynthia L Toth; Lei Ding; Youmin Zhang; James M May; Sergio Fazio; Kasey C Vickers; MacRae F Linton Journal: J Lipid Res Date: 2014-09-19 Impact factor: 5.922
Authors: Marten A Hoeksema; Marion Jj Gijbels; Jan Van den Bossche; Saskia van der Velden; Ayestha Sijm; Annette E Neele; Tom Seijkens; J Lauran Stöger; Svenja Meiler; Marieke Cs Boshuizen; Geesje M Dallinga-Thie; Johannes Hm Levels; Louis Boon; Shannon E Mullican; Nathanael J Spann; Jack P Cleutjens; Chris K Glass; Mitchell A Lazar; Carlie Jm de Vries; Erik Al Biessen; Mat Jap Daemen; Esther Lutgens; Menno Pj de Winther Journal: EMBO Mol Med Date: 2014-09 Impact factor: 12.137